These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 47482)
1. Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs. Mukhtar ED; Smith BR; Pyle GA; Hall R; Vice P Lancet; 1975 Mar; 1(7909):713-5. PubMed ID: 47482 [TBL] [Abstract][Full Text] [Related]
2. The effect of radioiodine and antithyroid drugs on serum long acting thyroid stimulator protector (IATS-P). A three year prospective study. Hardisty CA; Fowles A; Munro DS Clin Endocrinol (Oxf); 1984 May; 20(5):597-605. PubMed ID: 6547647 [TBL] [Abstract][Full Text] [Related]
3. [Long-term evolution of immunologic and thyroid function in Graves disease according different therapeutic options]. Campos Pastor MM; Fernández Soto ML; Escobar-Jiménez F; Barredo Acedo F; Ruiz de Almodóvar M Med Clin (Barc); 1994 Apr; 102(12):446-50. PubMed ID: 7516033 [TBL] [Abstract][Full Text] [Related]
4. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy. Sabri O; Zimny M; Schreckenberger M; Reinartz P; Ostwald E; Buell U Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656 [TBL] [Abstract][Full Text] [Related]
5. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease. Nakazato N; Yoshida K; Mori K; Kiso Y; Sayama N; Tani JI; Nakagawa Y; Ito S Thyroid; 1999 Aug; 9(8):775-9. PubMed ID: 10482369 [TBL] [Abstract][Full Text] [Related]
6. Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins. Bech K Acta Endocrinol Suppl (Copenh); 1983; 254():3-38. PubMed ID: 6191508 [No Abstract] [Full Text] [Related]
7. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. Chiovato L; Fiore E; Vitti P; Rocchi R; Rago T; Dokic D; Latrofa F; Mammoli C; Lippi F; Ceccarelli C; Pinchera A J Clin Endocrinol Metab; 1998 Jan; 83(1):40-6. PubMed ID: 9435414 [TBL] [Abstract][Full Text] [Related]
8. Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease. Edan G; Massart C; Hody B; Poirier JY; Lé Reun M; Hespel JP; Leclech G; Simon M BMJ; 1989 Feb; 298(6670):359-61. PubMed ID: 2564286 [TBL] [Abstract][Full Text] [Related]
9. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819 [TBL] [Abstract][Full Text] [Related]
10. Long-acting thyroid stimulator and thyroid function in relatives of patients with Graves' disease. Bonnyns M; Vanhaerlst L; Golstein J; Cauchie C; Ermans AM; Bastenie PA Clin Endocrinol (Oxf); 1973 Jul; 2(3):277-87. PubMed ID: 4128244 [No Abstract] [Full Text] [Related]
11. Evidence that thyroid-stimulating antibody is produced in the thyroid gland. Kendall-Taylor P; Knox AJ; Steel NR; Atkinson S Lancet; 1984 Mar; 1(8378):654-6. PubMed ID: 6142350 [TBL] [Abstract][Full Text] [Related]
12. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report. Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094 [TBL] [Abstract][Full Text] [Related]
13. Prediction of outcome in Graves' disease after carbimazole treatment. Weetman AP; Ratanachaiyavong S; Middleton GW; Love W; John R; Owen GM; Darke C; Lazarus JH; Hall R; McGregor AM Q J Med; 1986 Apr; 59(228):409-19. PubMed ID: 2875484 [TBL] [Abstract][Full Text] [Related]
14. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group. Törring O; Tallstedt L; Wallin G; Lundell G; Ljunggren JG; Taube A; Sääf M; Hamberger B J Clin Endocrinol Metab; 1996 Aug; 81(8):2986-93. PubMed ID: 8768863 [TBL] [Abstract][Full Text] [Related]
15. [Basedow's disease]. Scheidegger K Schweiz Rundsch Med Prax; 1993 Aug; 82(32):840-4. PubMed ID: 7690495 [TBL] [Abstract][Full Text] [Related]
16. Recurrent thyrotoxicosis after subtotal thyroidectomy. Hedley AJ; Ross IP; Beck JS; Donald D; Albert-Recht F; Michie W; Crooks J Br Med J; 1971 Oct; 4(5782):258-61. PubMed ID: 5171384 [TBL] [Abstract][Full Text] [Related]
18. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Laurberg P; Bournaud C; Karmisholt J; Orgiazzi J Eur J Endocrinol; 2009 Jan; 160(1):1-8. PubMed ID: 18849306 [TBL] [Abstract][Full Text] [Related]
19. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism]. Jukić T; Stanicić J; Petric V; Kusić Z Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325 [TBL] [Abstract][Full Text] [Related]
20. Thyroid function and immunological activity during and after medical treatment of Graves' disease. Gossage AA; Crawley JC; Copping S; Hinge D; Himsworth RL Clin Endocrinol (Oxf); 1983 Jul; 19(1):87-96. PubMed ID: 6137296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]